
Screening for breast / ovarian cancer risk genes other than BRCA1/2 is clinically valuable
A study by researchers at three academic medical centers has shown that screening women with a suspected risk of hereditary breast or ovarian cancer for risk-associated genes other than BRCA1 and 2 provides information that ...
Aug 13, 2015
0
126